Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intestinal decolonization of 3GCREB carriage with colistin plus rifaximin
DRKS00006330Phase 2Terminated
- Sponsor
- Universitätsklinikum Freiburg
- Start
- May 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of colistin and rifaximin in Enteric diseases and Intestinal carriage of third-generation cephalosporin-resistant Enterobacteriaceae (2 arms), sponsored by Universitätsklinikum Freiburg. Started May 2015; status: terminated.
02
Drugs
colistinrifaximin
03
Conditions
Enteric diseasesIntestinal carriage of third-generation cephalosporin-resistant Enterobacteriaceae
Beyond the preview
Go deeper on DRKS00006330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00006330.